No Detail Found!

Effect of Remdesivir on mortality and length of stay in hospitalized COVID-19 patients: A single center study

Author(s)
Quratulain Shaikh Indus Hospital Research Center, The Indus Hospital and Health Network, Karachi, Pakistan.
Samreen Sarfaraz Indus Hospital Research Center, The Indus Hospital and Health Network, Karachi, Pakistan.
Anum Rahim Indus Hospital Research Center, The Indus Hospital and Health Network, Karachi, Pakistan.
Mujahid Hussain Department of Pharmacy Services, The Indus Hospital and Health Network, Karachi, Pakistan.
Rabeea Shah Department of Internal Medicine, The Indus Hospital and Health Network, Karachi, Pakistan.
Sara Soomro Department of Internal Medicine, The Indus Hospital and Health Network, Karachi, Pakistan.
Abstract
Objectives: To see the difference in mortality among hospitalized COVID-19 patients given Remdesivir (RDV) with those who were not given RDV. Methods: A prospective cohort study was conducted on patients who were admitted to the COVID-19 isolation unit at The Indus Hospital, Korangi Campus Karachi between March and June 2020. Results: Groups were similar in age and gender distribution. RDV group was more hypoxic, had severe ARDS and needed higher Oxygen support compared to non-RDV group (p=0.000). Median SOFA score was 2 in RDV vs 5 in non-RDV (p=0.000). More than moderate COVID pneumonia was found in 92% of the RDV group while 89% of non-RDV group (p value=0.001). Median day of illness to administer Remdesivir was 10. There was no difference in mortality (45.5% in RDV vs 40.4% in non-RDV; p=0.4) between the two groups. Median length of hospital stay was 12 days (IQR=7.5-14.5) in RDV group compared to 10 days (IQR=6-14) in non-RDV group (p=0.009). Conclusion: RDV did not show any difference in in-hospital mortality in our patients. More patients had severe ARDS in the RDV group while patients in the non-RDV group had higher SOFA score and multi-organ failure. Length of stay was longer in patients receiving Remdesivir.
Publication Details
Page(s) 405-410
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 38, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
COVID-19, Mortality, ARDS, Covid-19, Remdesivir
0

Citations

0

Downloads

83

Views